SCHEMBL30880609

SCHEMBL30880609

COc1cc(Nc2ccnc3cc(OC)c(C(N)=O)cc23)cc(-c2ccnn2C)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PDGFRA P16234 2/20 0.47
▸ EGFR P00533 2/20 0.44
▸ RIPK2 O43353 4/20 0.44
▸ GAK O14976 3/20 0.44
▸ COQ8A Q8NI60 3/20 0.44
▸ NLK Q9UBE8 3/20 0.44
▸ ABL1 P00519 2/20 0.44
▸ LCK P06239 2/20 0.44
▸ MAP2K5 Q13163 2/20 0.44
▸ BMPR1B O00238 1/20 0.44
▸ EPHB6 O15197 1/20 0.44
▸ SRC P12931 1/20 0.44
▸ EPHA1 P21709 1/20 0.44
▸ EPHA8 P29322 1/20 0.44
▸ ACVR1 Q04771 1/20 0.44
▸ RET P07949 9/20 0.42
▸ KDR P35968 4/20 0.42
▸ MET P08581 3/20 0.42
▸ TEK Q02763 3/20 0.42
▸ AURKB Q96GD4 3/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30880601 0.88 GAK (0.57) PDGFRAEGFRRIPK2GAKCOQ8A
SCHEMBL30880471 0.85 SYK (0.47) PDGFRAEGFRRIPK2GAKCOQ8A
SCHEMBL30880566 0.84 PDGFRA (0.51) PDGFRAEGFRRIPK2GAKCOQ8A
SCHEMBL30880629 0.84 PDGFRA (0.51) PDGFRAEGFRRIPK2GAKCOQ8A
SCHEMBL30880530 0.84 PDGFRA (0.48) PDGFRAEGFRRIPK2GAKCOQ8A
SCHEMBL30880548 0.84 PDGFRA (0.48) PDGFRAEGFRRIPK2GAKCOQ8A
SCHEMBL30880619 0.81 PDGFRA (0.48) PDGFRAEGFRRIPK2GAKCOQ8A
SCHEMBL30880639 0.81 PDGFRA (0.48) PDGFRAEGFRRIPK2GAKCOQ8A
SCHEMBL30880518 0.81 MKNK1 (0.51) PDGFRAEGFRRIPK2GAKCOQ8A
SCHEMBL30880535 0.81 PDGFRA (0.48) PDGFRAEGFRRIPK2GAKCOQ8A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024078513-A1 CONDENSED AZINES FOR TREATING CANCER CHENGDU ANTICANCER BIOSCIENCE , LTD. (CN) 2024-04-18 — — WO disclosed
Send feedback